NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

Sounds good. So you think they may be waiting for a reply from the FDA regarding NWBO's final, final proposed subgroups scheme, or some other related issue.

I like that. I like it because I don't remember them talking about mesenchymal as a subgroup in the past, and I want to believe that subgroup shows great response.

Mesenchymal more immunogenic... why would that be? Less blockade function? If so, then clearly it would have to have other things going for it, as a cancer, that offset that weakness. But perhaps those other things are no match for DCVax-L... if it does lack blockade function.